≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Sexual dysfunction

DOID EFO Endpoint Browser PheWeb

F5_SEXDYS

sexual dysfunction: ['Disturbances in sexual desire and the psychophysiologic changes that characterize the sexual response cycle and cause marked distress and interpersonal difficulty.']

Suggest a new description

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — F52
  • Hospital discharge: ICD-9 — 3027
  • Cause of death: ICD-10 — F52
  • Cause of death: ICD-9 — 3027

2 out of 7 registries used, show all original rules.

555

4. Check minimum number of events

None

555

5. Include endpoints

None

555

6. Filter based on genotype QC (FinnGen only)

555

Control definitions (FinnGen only)

Control exclude
F5_BEHAVE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
F50-F59
Name in latin
Perturbationes sexuales non organicae

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 3670 859 2778
Only index persons 3531 836 2695
Unadjusted period prevalence (%)
Whole population 0.06 0.02 0.08
Only index persons 0.09 0.03 0.10
Median age at first event (years)
Whole population 40.63 32.07 43.31
Only index persons 40.15 31.85 42.72

-FinnGen-

Key figures

All Female Male
Number of individuals 555 160 395
Unadjusted period prevalence (%) 0.14 0.05 0.17
Median age at first event (years) 47.78 37.94 51.77

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
479
Matched controls
4788
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F52.2
ICD-10 Finland
Failure of genital response
94.6
186.1
200
36
F52.0
ICD-10 Finland
Lack or loss of sexual desire
211.9
86.4
87
5
F52.9
ICD-10 Finland
Unspecified sexual dysfunction, not caused by organic disorder or disease
297.3
53.3
53
*
F52.6
ICD-10 Finland
Nonorganic dyspareunia
200.0
36.3
37
*
N48.4
ICD-10 Finland
Impotence of organic origin
13.5
34.5
61
51
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
6.6
34.4
95
173
F52
ICD-10 Finland
Sexual dysfunction, not caused by organic disorder or disease
35.4
23.6
30
9
F52.4
ICD-10 Finland
Premature ejaculation
126.1
22.8
24
*
F52.8
ICD-10 Finland
Other sexual dysfunction, not caused by organic disorder or disease
76.8
19.9
22
*
F52.3
ICD-10 Finland
Orgasmic dysfunction
+∞
17.8
17
*
N05AH04
ATC
quetiapine; oral
3.0
17.5
113
443
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.3
16.8
93
326
F52.5
ICD-10 Finland
Nonorganic vaginismus
+∞
16.8
16
*
N06AX11
ATC
mirtazapine; oral
2.4
16.1
168
868
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.5
14.0
70
226
N06AB05
ATC
paroxetine; oral
4.2
13.3
52
136
N94.1
ICD-10 Finland
Dyspareunia
15.6
13.2
21
14
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
4.7
12.9
44
101
N06AB06
ATC
sertraline; oral
3.1
12.7
73
261
N06AX12
ATC
bupropion; oral
3.8
12.4
54
156
Z3231
NOMESCO Finland
Registered nurse
2.3
12.3
136
706
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
5.0
11.9
38
81
N05AX12
ATC
aripiprazole; systemic
4.6
11.9
41
95
N05BA04
ATC
oxazepam; oral
2.3
11.8
121
606
N06AB04
ATC
citalopram; systemic
2.4
11.6
114
557
F50.9
ICD-10 Finland
Eating disorder, unspecified
122.8
11.5
12
*
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
4.7
10.7
36
82
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
3.2
10.5
55
184
N05CF01
ATC
zopiclone; oral
2.1
10.3
134
741
N05AH03
ATC
olanzapine; systemic
3.5
10.3
49
153
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
3.0
10.1
59
213
XKD00
NOMESCO Finland
Uroflowmetry
2.5
10.1
86
388
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
9.9
122
658
N06AX16
ATC
venlafaxine; oral
2.6
9.8
77
333
Z2221
NOMESCO Finland
Medical doctor
2.1
9.5
132
748
F34.1
ICD-10 Finland
Dysthymia
5.1
9.5
29
60
XCW99
NOMESCO Finland
Other investigative procedure of eye
3.1
9.4
53
187
N06AB10
ATC
escitalopram; oral
2.2
9.3
111
586
N02AX02
ATC
tramadol; systemic, rectal
1.9
9.2
185
1201
N03AE01
ATC
clonazepam; systemic
3.7
9.2
39
111
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
3.3
9.1
45
145
R06.0
ICD-10 Finland
Dyspnoea
2.2
9.1
106
558
A04
ICPC
Weakness/tiredness general
2.8
9.0
59
228
ZXD10
NOMESCO Finland
Scheduled procedure
1.9
9.0
164
1028
P29
ICPC
Psychological sympt/compl other
3.4
9.0
43
135
R07.4
ICD-10 Finland
Chest pain, unspecified
2.1
9.0
118
653
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.5
8.9
71
307
F51.0
ICD-10 Finland
Nonorganic insomnia
2.6
8.9
65
269
Z01.7
ICD-10 Finland
Laboratory examination
2.8
8.8
58
224
N05CD07
ATC
temazepam; oral
2.9
8.8
54
201
N03AG01
ATC
valproic acid; systemic, rectal
3.3
8.8
43
138
N05BA01
ATC
diazepam; systemic, rectal
2.6
8.7
67
284
K59.09
ICD-10 Finland
Constipation, unspecified
4.2
8.7
32
80
A06AC01
ATC
ispaghula (psylla seeds); oral
2.2
8.6
94
477
Z3226
NOMESCO Finland
Physiotherapist
2.2
8.5
90
453
N03AX09
ATC
lamotrigine; oral
3.6
8.4
37
109
N05AX08
ATC
risperidone; systemic
3.0
8.2
47
168
R51.80
ICD-10 Finland
Headache
2.3
8.1
76
357
H04.10
ICD-10 Finland
Dry eye syndrome
3.2
8.1
41
135
R53
ICD-10 Finland
Malaise and fatigue
2.2
8.0
89
457
SPAT1240
SPAT
Therapeutic discussion
2.4
8.0
66
294
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.1
7.7
91
479
A02BC02
ATC
pantoprazole; systemic
1.7
7.7
272
2076
N06AB03
ATC
fluoxetine; oral
2.5
7.7
61
265
R4110
NOMESCO Finland
Physiotherapy
1.9
7.6
117
683
C07AA05
ATC
propranolol; systemic
2.1
7.6
88
460
F41.1
ICD-10 Finland
Generalized anxiety disorder
3.8
7.5
30
82
Z71.8
ICD-10 Finland
Other specified counselling
1.9
7.4
112
649
R35
ICD-10 Finland
Polyuria
3.2
7.4
38
127
N06AX22
ATC
agomelatine; oral
7.0
7.4
17
25
3027C
ICD-9 Finland
Sexual deviations and disorders, Psychosexual dysfunction[SEKSUAALINEN KIIHOTTUMISVAIKEUS]
+∞
7.3
7
*
N05CF02
ATC
zolpidem; oral
2.1
7.3
84
438
N05AB03
ATC
perphenazine; systemic, rectal
3.9
7.2
28
75
SAA01
NOMESCO Finland
Simple examination of mouth
1.7
7.0
337
2775
XKD06
NOMESCO Finland
Physiologic investigation of micturition
4.8
7.0
22
48
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
6.9
149
972
R06.5
ICD-10 Finland
Mouth breathing
2.4
6.8
56
247
N06AG02
ATC
moclobemide; oral
3.8
6.8
27
74
N01
ICPC
Headache
2.6
6.8
50
209
G04BE04
ATC
yohimbine; oral
17.0
6.8
10
6
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
2.9
6.7
40
148
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
6.7
151
996
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.9
6.6
97
552
S18
ICPC
Laceration/cut
1.7
6.6
174
1203
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.9
6.4
108
648
F50.2
ICD-10 Finland
Bulimia nervosa
70.8
6.4
7
*
ZY010
NOMESCO Finland
Hospital outpatient
3.3
6.4
30
94
N03AX16
ATC
pregabalin; oral
1.9
6.4
99
574
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
5.6
6.4
17
31
N03AX12
ATC
gabapentin; oral
2.2
6.4
65
320
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.2
6.3
62
298
E73.8
ICD-10 Finland
Other lactose intolerance
+∞
6.3
6
*
Z70.9
ICD-10 Finland
Sex counselling, unspecified
27.1
6.2
8
*
L03
ICPC
Low back symptom/complaint
1.9
6.2
101
596
R10.2
ICD-10 Finland
Pelvic and perineal pain
5.9
6.2
16
28
A02BC03
ATC
lansoprazole; oral
1.8
6.2
112
688
R01AD09
ATC
mometasone; nasal
1.6
6.2
201
1465
N06AX21
ATC
duloxetine; oral
2.3
6.1
54
247
A02BA02
ATC
ranitidine; systemic
2.1
6.1
69
354
Z2446
NOMESCO Finland
Social worker
2.9
6.1
35
127

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3017446) Testosterone [Moles/volume] in Serum or Plasma
176
591
3.90
45.09
3.3
2.2
nmol/l
14.1
13.8
0.12
168
547
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
100
262
4.44
35.41
2.4
1.7
nmol/l
35.6
37.8
0.55
100
253
(3009214) Lutropin [Units/volume] in Serum or Plasma
72
184
4.35
26.05
1.6
1.4
u/l
5.4
7.7
1.42
60
157
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
407
3122
2.14
13.95
4.8
3.4
pmol/l
14.6
14.7
0.13
382
2872
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
471
3896
2.38
12.38
5.7
4.0
mu/l
1.9
1.8
0.03
443
3613
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
27
57
4.93
12.25
1.9
1.5
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
346
2576
1.91
11.96
4.8
3.6
e6/l
178.7
132.7
—
6
35
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
221
1459
1.86
10.85
2.2
1.8
pmol/l
99.1
94.4
0.81
120
817
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
121
656
2.08
10.56
2.1
1.9
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
306
2244
1.81
10.54
7.6
6.4
e9/l
0.2
0.2
0.28
273
2012
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
58
234
2.65
9.97
3.1
3.7
pmol/l
4.6
4.7
0.33
51
212
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
401
3226
1.88
9.85
9.2
7.9
u/l
76.8
76.8
0.01
379
3068
(3006315) Basophils [#/volume] in Blood
295
2171
1.77
9.75
7.6
6.0
e9/l
0.0
0.0
0.08
263
1925
(3001604) Monocytes [#/volume] in Blood
294
2165
1.76
9.67
7.5
6.0
e9/l
0.6
0.6
0.01
260
1916
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
212
1424
1.79
9.55
3.5
3.0
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
300
2241
1.74
9.21
7.5
6.2
e9/l
1.8
2.0
1.20
270
2011
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
223
1540
1.75
9.01
2.8
2.2
nmol/l
73.7
72.5
0.27
207
1417
(3013707) Erythrocyte sedimentation rate by Westergren method
386
3110
1.79
8.95
4.5
3.7
mm/h
9.6
9.9
0.12
371
2907
(3001122) Ferritin [Mass/volume] in Serum or Plasma
254
1824
1.72
8.89
3.3
2.6
ug/l
116.5
139.1
0.94
241
1719
(3013650) Neutrophils [#/volume] in Blood by Automated count
325
2499
1.73
8.84
11.9
9.5
e9/l
3.8
4.1
1.62
286
2212
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
253
1818
1.72
8.81
8.8
7.4
mmol/l
1.2
1.2
0.24
227
1572
(3011397) Hemoglobin [Presence] in Urine by Test strip
144
882
1.85
8.65
3.7
3.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
124
726
1.91
8.56
2.3
2.0
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
145
895
1.84
8.48
2.2
2.0
mg/l
2.7
2.9
0.62
131
786
(3037467) Urinalysis macro (dipstick) panel - Urine
358
2852
1.72
8.32
4.2
3.7
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
69
329
2.25
8.25
1.4
1.2
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
232
1651
1.70
8.22
8.2
6.6
mmol/l
1.2
1.2
0.12
216
1525
(3007164) IgA [Mass/volume] in Serum or Plasma
144
897
1.82
8.14
1.6
1.3
g/l
2.3
2.4
0.40
89
594
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
172
1136
1.74
7.94
2.9
2.1
u/l
337.8
275.0
0.23
160
1082
(3022096) Basophils/100 leukocytes in Blood
265
1971
1.66
7.81
7.5
6.3
%
0.7
0.7
0.82
254
1868
(46235355) HIV 1 and 2 tests - Meaningful Use set
165
1082
1.75
7.79
2.2
1.9
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
273
2050
1.65
7.73
7.8
6.6
%
8.8
8.6
0.54
262
1951
(3018010) Neutrophils/100 leukocytes in Blood
277
2088
1.65
7.72
7.2
6.0
%
56.2
57.0
0.45
265
1988
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
123
742
1.84
7.67
4.3
3.5
ng/l
172.1
663.9
2.04
86
542
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
114
674
1.87
7.57
3.2
2.5
e6/l
0.4
1.0
1.88
56
396
(3030467) Casts [#/volume] in Urine by Automated count
164
1083
1.73
7.51
3.7
2.9
e6/l
0.2
0.4
0.64
112
833
(3006504) Eosinophils/100 leukocytes in Blood
270
2040
1.63
7.33
7.6
6.2
%
3.1
2.9
0.81
257
1929
(3002030) Lymphocytes/100 leukocytes in Blood
278
2118
1.63
7.28
7.6
6.2
%
28.8
28.2
0.39
265
2008
(3023323) Follitropin [Units/volume] in Serum or Plasma
45
189
2.50
7.14
1.7
1.3
iu/l
15.2
20.7
0.63
36
158
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
187
1297
1.67
7.07
3.7
2.8
u/l
56.6
57.5
0.15
174
1222
(3018095) Leukocytes [#/volume] in Urine
198
1394
1.65
7.06
4.4
3.3
e6/l
71.9
107.5
0.33
130
1013
(3018418) pH of Serum or Plasma
157
1042
1.71
6.99
6.2
4.4
ph
7.4
7.4
0.03
17
191
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
107
637
1.84
6.91
3.3
2.7
e6/l
0.9
1.2
0.58
49
362
(40768797) Stomach Pathology biopsy report
93
531
1.90
6.84
1.3
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
148
975
1.71
6.74
1.4
1.2
u/ml
3.3
1.0
0.71
44
287
(40758558) Short blood count panel - Blood
153
1018
1.69
6.72
7.4
6.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
158
1067
1.67
6.53
3.8
2.8
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
174
1206
1.65
6.50
3.7
2.9
e6/l
29.7
99.8
0.70
121
950
(40768804) Tissue Pathology biopsy report
215
1571
1.60
6.47
2.1
2.0
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
106
642
1.80
6.45
2.8
3.6
mmol/l
0.8
0.8
0.07
97
616
(3019550) Sodium [Moles/volume] in Serum or Plasma
501
4527
2.10
6.40
19.5
13.6
mmol/l
139.6
139.7
0.07
491
4413
(3024561) Albumin [Mass/volume] in Serum or Plasma
221
1630
1.59
6.37
5.1
5.5
g/l
36.4
36.4
0.03
204
1542
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
500
4525
2.06
6.20
17.7
12.5
mg/l
21.5
23.3
0.63
406
3491
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
39
164
2.48
6.19
3.4
2.6
u/l
1008.8
2797.7
—
9
63
(3021960) Folate [Moles/volume] in Serum or Plasma
127
822
1.71
6.11
1.8
1.4
nmol/l
20.2
19.8
0.14
118
711
(3023103) Potassium [Moles/volume] in Serum or Plasma
501
4544
2.05
6.06
20.0
13.8
mmol/l
4.0
4.0
0.11
492
4424
(3013826) Glucose [Moles/volume] in Serum or Plasma
308
2476
1.55
5.94
6.0
5.0
mmol/l
6.9
6.7
0.80
295
2311
(3033658) Prothrombin time (PT) actual/Normal
150
1028
1.63
5.77
4.3
4.0
%
90.6
90.9
0.05
143
1014
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
476
4268
1.81
5.65
5.1
4.0
mmol/l
6.1
5.9
1.06
442
3963
(42870588) Differential panel, method unspecified - Blood
192
1408
1.56
5.50
6.7
6.0
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
90
545
1.78
5.44
3.6
2.4
g/l
2.3
2.3
0.42
83
508
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
454
4035
1.69
5.34
6.7
5.1
mmol/mol
40.2
39.5
0.73
434
3819
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
271
2151
1.51
5.33
7.2
7.0
umol/l
11.4
11.9
0.23
254
2050
(3016879) Cocaine [Presence] in Urine
50
250
2.10
5.33
2.3
1.9
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
102
646
1.71
5.27
1.5
1.2
u/ml
14.0
7.7
0.51
48
262
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
84
504
1.79
5.24
3.8
2.5
%
23.4
24.5
0.39
78
440
(3048689) Calprotectin [Mass/mass] in Stool
93
575
1.74
5.23
1.8
2.5
ug/g
113.8
122.2
0.11
72
475
(3036481) Cortisol [Moles/volume] in Serum or Plasma
68
382
1.89
5.23
2.3
1.9
nmol/l
372.1
365.4
0.10
62
358
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
203
1533
1.51
4.98
3.8
3.7
u/l
33.9
34.7
0.10
193
1461
(3007853) Bacteria identified in Skin by Aerobe culture
81
488
1.77
4.98
2.2
1.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
137
949
1.59
4.96
1.9
1.7
mg/l
0.6
1.2
5.12
107
717
(3022217) INR in Platelet poor plasma by Coagulation assay
76
450
1.80
4.95
20.9
20.6
inr
1.2
1.3
0.28
11
64
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
106
692
1.66
4.87
1.5
1.2
iu/ml
16.9
30.1
1.39
23
213
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
9
10
9.12
4.80
1.7
1.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
28
114
2.53
4.79
3.2
2.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
256
2039
1.47
4.78
3.8
3.0
estimate
0.0
0.0
0.00
27
367
(3003458) Phosphate [Moles/volume] in Serum or Plasma
82
503
1.74
4.73
9.0
6.8
mmol/l
1.1
1.0
0.93
76
482
(1001926) Buprenorphine [Presence] in Urine by Screen method
42
206
2.12
4.72
2.6
1.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
470
4256
1.68
4.66
14.8
10.9
ml/min/173m2
87.6
88.0
0.13
397
3494
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
44
221
2.08
4.65
6.2
4.5
ng/l
113.4
87.4
0.83
38
204
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
53
285
1.95
4.65
1.5
1.6
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
113
759
1.61
4.63
2.4
1.9
%
1.5
1.5
0.23
103
687
(3015377) Calcium [Moles/volume] in Serum or Plasma
163
1191
1.52
4.62
3.4
3.5
mmol/l
2.4
2.3
0.54
143
1074
(3009508) Creatinine [Moles/volume] in Urine
175
1303
1.50
4.52
3.6
3.2
mmol/l
8.4
8.7
0.30
154
1124
(3027944) Amphetamines [Presence] in Urine
50
269
1.94
4.39
1.6
1.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
384
3341
1.48
4.37
4.0
3.2
u/l
44.1
49.7
0.81
361
3192
(3000764) Benzodiazepines [Presence] in Urine
50
270
1.94
4.34
2.3
1.9
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
136
967
1.54
4.34
2.7
3.0
ng/l
685.1
1038.4
1.55
114
813
(3035350) Ketones [Presence] in Urine by Test strip
251
2021
1.44
4.29
3.8
3.0
estimate
0.0
0.0
0.00
29
386
(3000494) Fungus identified in Specimen by Culture
82
517
1.69
4.29
1.6
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
26
108
2.48
4.28
3.0
3.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
29
127
2.35
4.27
1.9
1.6
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
88
566
1.66
4.27
1.6
1.3
titre
240.0
409.7
1.70
15
103
(3027008) Opiates [Presence] in Urine
50
272
1.92
4.25
2.3
1.9
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
98
650
1.62
4.21
2.0
1.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
250
2017
1.44
4.20
4.9
4.2
estimate
0.0
0.0
0.00
29
395
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
40
202
2.06
4.19
1.7
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
50
274
1.91
4.16
2.3
1.8
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
36
175
2.13
4.16
4.9
3.5
mmol/l
24.4
24.0
0.34
30
162
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
76
475
1.70
4.10
6.7
6.4
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
18
63
2.92
4.10
1.7
1.4
pmol/l
32.4
51.1
—
9
18
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
9
14
6.51
3.99
2.0
2.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
25
106
2.42
3.96
1.3
1.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
116
816
1.53
3.86
2.9
2.4
e6/l
3.4
5.2
0.69
102
725
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
212
1684
1.42
3.78
3.5
3.7
%
24.4
21.1
2.03
83
687
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
254
2084
1.40
3.75
4.2
4.2
ug/l
2.5
2.0
0.22
233
1898
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
58
347
1.75
3.67
3.0
2.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
31
150
2.13
3.64
1.2
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
150
1931
0.69
3.55
3.1
2.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
125
909
1.48
3.53
3.9
3.2
kg/l
1.0
1.0
0.65
11
122
(3026008) Bacteria identified in Urine by Culture
120
872
1.48
3.39
3.2
2.6
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
12
37
3.29
3.36
1.8
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
51
302
1.76
3.35
2.3
2.4
ml/min/173m2
71.7
73.0
0.05
19
123
(3012516) Albumin [Mass/volume] in Urine
150
1142
1.43
3.32
3.6
3.4
mg/l
419.5
231.3
0.21
112
786
(44816559) Phosphatidylethanol [Mass/volume] in Blood
26
122
2.19
3.31
1.1
1.2
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
21
90
2.39
3.28
1.0
1.1
u/ml
2.2
6.6
—
10
50
(3026782) Osmolality of Urine
107
765
1.49
3.27
2.9
2.6
mosm/kgh2o
533.7
585.6
1.68
86
660
(3019309) Folate [Moles/volume] in Red Blood Cells
87
595
1.55
3.27
1.9
1.6
nmol/l
1276.7
1190.6
0.19
70
481
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
40
222
1.86
3.24
1.1
1.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
52
313
1.73
3.23
3.8
3.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
34
180
1.95
3.17
1.5
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
489
4572
1.58
3.11
5.4
4.3
mmol/l
2.8
2.8
0.76
463
4295
(3011288) Drugs identified in Urine by Screen method
33
175
1.94
3.07
3.7
2.4
—
—
—
0
0
(4198724)
10
29
3.49
3.06
2.1
1.4
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
8
17
4.76
2.93
1.6
1.4
u/l
11.5
15.4
—
8
17
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
9
6.72
2.87
4.7
5.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
6
9
6.72
2.87
1.0
1.0
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
6
9
6.72
2.87
1.3
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
86
604
1.50
2.87
2.6
2.1
—
—
—
0
0
(3044889) 12 lead EKG panel
341
3013
1.34
2.84
4.2
3.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
46
279
1.71
2.81
2.8
1.9
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
193
1572
1.35
2.78
4.2
3.2
ng/l
19.3
39.9
3.67
113
979
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
24
118
2.08
2.75
1.2
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
373
3348
1.35
2.75
3.3
3.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
113
845
1.42
2.73
1.8
1.7
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
55
354
1.61
2.69
4.9
3.3
mmol/l
1.9
1.8
0.12
47
279
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
9
24
3.79
2.68
5.8
2.7
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
60
395
1.58
2.68
3.7
2.9
%
1.7
1.7
0.11
54
359
(3008401) Mugwort IgE Ab [Units/volume] in Serum
19
86
2.25
2.66
1.0
1.1
u/ml
0.4
1.0
—
10
32
(3021447) Carbon dioxide [Partial pressure] in Venous blood
55
356
1.60
2.63
4.7
3.3
kpa
5.9
5.7
0.35
50
346
(3026493) Urate [Moles/volume] in Serum or Plasma
141
1106
1.37
2.56
2.4
2.6
umol/l
364.4
5966.8
3.55
121
988
(3004616) Nuclear Ab [Presence] in Serum
12
44
2.77
2.56
1.2
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
511
4865
1.64
2.55
13.1
9.6
u/l
28.7
30.9
1.90
499
4737
(3001556) Androgen free Index in Serum or Plasma
6
11
5.50
2.55
1.2
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
83
594
1.47
2.53
3.4
3.2
mmol/l
2.4
2.4
0.38
72
528
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
127
982
1.38
2.52
2.7
2.3
—
—
—
0
0
(3019225) pH of Specimen
53
345
1.59
2.49
4.8
4.4
—
—
—
0
0
(3000991) Gas panel - Venous blood
52
337
1.60
2.49
13.1
9.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
125
967
1.38
2.47
1.5
1.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
13
51
2.59
2.46
1.5
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
23
117
2.01
2.44
1.2
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
10
34
2.98
2.42
2.1
2.4
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
10
34
2.98
2.42
5.6
1.4
mosm/kgh2o
288.8
285.4
—
5
27
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
85
617
1.45
2.41
2.1
1.9
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
155
1245
1.34
2.41
2.5
2.7
ug/l
0.7
0.7
0.36
95
724
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
20
97
2.10
2.40
1.0
1.1
u/ml
0.2
2.6
—
9
41
(42529406) Shigella sp [Presence] in Stool by Culture
23
118
1.99
2.39
1.2
1.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
224
1901
1.30
2.34
11.7
9.0
e9/l
0.0
0.0
0.55
180
1577
(3021901) Oxygen saturation in Capillary blood
15
65
2.34
2.33
1.6
2.0
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
478
4507
1.44
2.29
4.9
4.0
mmol/l
1.3
1.4
1.47
455
4245
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
23
120
1.96
2.29
3.0
3.1
mg/l
1.4
1.4
0.16
23
112
(3023368) Bacteria identified in Blood by Culture
136
1079
1.34
2.28
5.7
4.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
29
164
1.81
2.27
2.3
2.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
479
4522
1.43
2.24
5.0
4.0
mmol/l
4.6
4.7
1.39
456
4274
(3022145) Colonoscopy Study observation
68
480
1.47
2.23
1.4
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
38
235
1.66
2.20
1.6
1.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
40
252
1.63
2.16
2.6
3.0
mmol/l
1.5
1.2
0.35
32
188
(3003396) Base excess in Arterial blood by calculation
63
441
1.48
2.16
9.5
9.6
mmol/l
0.9
0.9
0.01
49
350
(3006462) Nitrate [Presence] in Urine
6
14
4.32
2.15
2.8
1.8
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
21
109
1.96
2.13
1.3
1.4
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
5
10
5.03
2.07
1.0
1.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
148
1206
1.31
2.05
4.6
4.1
mg/mmol
8.2
10.3
0.39
107
820
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
230
1984
1.27
2.05
4.2
4.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
57
396
1.49
2.03
2.7
2.6
u/l
40.1
150.4
0.46
49
347
(3021879) Hepatitis B virus core Ab [Presence] in Serum
59
413
1.48
2.03
1.4
1.6
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
18
90
2.03
2.02
1.2
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
96
735
1.37
2.02
1.9
1.6
pmol/l
478.8
23920171.1
0.69
83
648
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
15
70
2.17
2.00
1.2
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
21
112
1.91
1.99
1.5
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
18
91
2.01
1.97
1.1
1.1
—
—
—
0
0
(44813793)
8
27
2.99
1.94
1.1
1.0
—
—
—
0
0
(4211845)
6
16
3.78
1.94
2.8
1.7
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
10
39
2.59
1.93
1.3
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
141
1151
1.30
1.92
1.7
1.7
mmol/l
1.4
1.5
0.36
123
996
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
41
602
0.66
1.86
1.7
1.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
462
4370
1.34
1.83
4.5
3.6
mmol/l
1.4
1.4
0.18
430
4112
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
5
12
4.19
1.82
1.8
1.7
umol/l
20.6
17.1
—
5
12
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
40
264
1.56
1.82
2.7
3.0
kpa
5.1
5.1
0.15
40
250
(3023520) Reticulocytes [#/volume] in Blood
43
289
1.53
1.81
2.2
3.0
e9/l
65.9
70.2
0.24
25
223
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
7
23
3.07
1.80
1.0
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
7
23
3.07
1.80
1.1
1.3
nmol/l
190.7
162.1
—
7
23
(3007461) Platelets [#/volume] in Blood
533
5178
1.74
1.80
26.2
17.9
e9/l
246.0
246.7
0.10
521
5071
(3032080) INR in Blood by Coagulation assay
187
1594
1.26
1.80
7.0
7.9
inr
1.1
1.2
0.71
38
494
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
45
307
1.51
1.77
2.3
2.3
—
19.6
—
0
21
(3023410) Appearance of Cerebral spinal fluid
10
41
2.47
1.76
1.7
1.6
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
8
30
2.69
1.73
1.1
1.6
g/l
33.7
34.7
—
8
24
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
8
30
2.69
1.73
8.5
6.6
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
8
30
2.69
1.73
4.4
3.3
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
7
24
2.94
1.72
1.3
1.3
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
7
24
2.94
1.72
2.0
2.5
u/ml
564.9
891.9
—
7
24
(3028679) Herpes simplex virus Ab [Presence] in Serum
7
24
2.94
1.72
1.3
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
36
235
1.57
1.72
1.7
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
47
326
1.48
1.72
5.1
4.6
%
0.0
0.2
3.56
13
100
(3026361) Erythrocytes [#/volume] in Blood
533
5184
1.71
1.70
26.3
17.8
e12/l
4.6
4.7
0.22
522
5074
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
119
1.79
1.68
2.7
2.2
g/l
3.8
3.9
0.16
16
85
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
119
1.79
1.68
2.7
2.2
g/l
7.7
7.2
0.49
16
91
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
119
1.79
1.68
2.7
2.2
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
533
5187
1.70
1.66
26.3
17.9
e9/l
6.7
6.7
0.04
522
5072
(3016018) Differential panel - Cerebral spinal fluid
10
43
2.35
1.61
1.6
1.3
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
8
32
2.52
1.60
1.0
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
24
144
1.70
1.60
1.8
2.0
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
46
323
1.46
1.59
3.9
4.4
%
0.4
0.3
—
10
84
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
64
478
1.38
1.59
1.5
1.5
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
6
20
3.02
1.58
1.0
1.0
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
7
157
0.44
1.57
1.6
1.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
12
57
2.13
1.56
1.1
2.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
26
161
1.65
1.55
2.0
1.6
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
8
33
2.44
1.54
2.4
2.8
mu/l
37.7
20.8
—
8
33
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
5
15
3.35
1.52
1.0
1.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
501
4826
1.39
1.52
14.6
11.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
11
51
2.18
1.51
1.1
2.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
58
430
1.39
1.51
2.1
1.8
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
21
2.88
1.51
1.2
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
23
139
1.68
1.50
1.5
1.6
iu/ml
0.3
0.1
—
5
27
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
23
139
1.68
1.50
1.4
1.3
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
41
285
1.47
1.50
2.0
1.6
g/l
1.0
1.4
1.96
41
265
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
14
72
1.97
1.50
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
14
72
1.97
1.50
1.4
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
59
440
1.38
1.48
2.1
1.8
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
16
87
1.86
1.47
2.0
3.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
25
156
1.63
1.46
2.3
2.7
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
29
188
1.57
1.46
1.3
1.4
—
9.1
—
0
11
(1002224) Polysomnography panel
39
271
1.47
1.44
1.1
1.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
5
16
3.14
1.44
5.8
4.6
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
9
39
2.33
1.43
1.2
1.9
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
27
407
0.65
1.42
1.4
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
24
150
1.63
1.40
1.8
1.7
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
7
29
2.43
1.39
1.1
1.8
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
5
121
0.41
1.39
1.6
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
48
350
1.41
1.38
5.0
4.5
%
0.5
0.8
0.62
14
110
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
122
0.40
1.38
1.6
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
152
1300
1.23
1.38
2.9
2.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
123
0.40
1.38
1.6
1.5
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
42
299
1.44
1.38
3.5
2.6
kpa
4.7
4.7
0.04
37
289
(3029937) Albumin [Presence] in Urine by Test strip
128
1075
1.25
1.37
4.7
3.2
estimate
0.0
0.0
0.88
27
371
(3034770) Mitochondria Ab [Titer] in Serum
23
143
1.63
1.37
1.4
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
15
82
1.85
1.37
1.4
1.4
—
—
—
0
0
(4133840)
5
17
2.96
1.36
1.6
1.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
43
309
1.42
1.35
5.3
4.6
%
0.0
0.2
0.91
12
86
(3016650) Hepatitis A virus Ab [Presence] in Serum
17
98
1.76
1.32
1.1
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
8
34
2.37
1.29
1.5
1.6
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
11
55
2.02
1.28
1.0
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
8
35
2.30
1.27
2.4
4.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
35
245
1.46
1.27
1.3
1.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
8
36
2.24
1.24
1.0
1.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
11
56
1.98
1.23
1.0
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
31
214
1.48
1.21
2.3
2.5
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
6
26
2.32
1.19
1.0
1.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
14
79
1.79
1.18
1.1
1.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
66
521
1.30
1.18
2.8
3.2
umol/l
8.1
9.2
0.13
56
459
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
8
39
2.07
1.15
1.3
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
8
39
2.07
1.15
2.5
3.3
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
20
2.51
1.15
1.0
2.3
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
20
2.51
1.15
1.0
2.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
34
242
1.43
1.15
1.1
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
22
143
1.56
1.13
1.4
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
11
58
1.91
1.12
1.6
1.5
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
34
244
1.42
1.10
5.2
9.1
mmol/l
23.5
24.3
0.47
34
229
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
21
2.39
1.09
1.2
2.3
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
7
32
2.20
1.08
1.1
1.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
7
32
2.20
1.08
1.0
1.2
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
7
32
2.20
1.08
1.1
1.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
10
52
1.94
1.06
1.1
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
37
272
1.39
1.06
1.2
1.3
iu/ml
26.3
158.7
—
8
109
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
7
33
2.14
1.06
1.0
1.0
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
8
148
0.53
1.05
1.5
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
8
148
0.53
1.05
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
8
149
0.53
1.05
1.5
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
8
149
0.53
1.05
1.5
1.4
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
22
2.28
1.03
1.0
2.3
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
22
2.28
1.03
1.0
2.3
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
22
2.28
1.03
1.0
2.3
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
22
2.28
1.03
1.2
2.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
11
60
1.85
1.03
1.6
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
11
60
1.85
1.03
1.6
1.5
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
7
34
2.07
1.03
1.6
1.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
7
34
2.07
1.03
1.1
1.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
11
189
0.57
1.02
1.2
1.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
180
1607
1.18
1.02
3.9
3.1
—
—
—
0
0
(4034850)
22
147
1.52
1.02
8.5
10.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
35
257
1.39
1.01
3.1
6.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
27
189
1.45
1.01
3.0
3.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
9
49
1.85
0.99
1.0
1.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
9
50
1.81
0.97
1.0
1.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
47
365
1.31
0.96
3.3
2.2
g/l
11.1
10.4
0.29
47
335
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
31
0.00
0.96
0.0
4.2
—
44.9
—
0
31
(4094501)
20
133
1.52
0.95
1.1
1.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
18
117
1.56
0.94
3.4
3.1
u/ml
0.5
0.3
—
9
64
(4306422)
12
70
1.73
0.93
1.3
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
32
237
1.37
0.90
3.3
2.3
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
12
72
1.68
0.85
1.6
1.2
u/ml
5.2
4.1
—
6
37
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
13
80
1.64
0.85
1.2
1.8
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
14
88
1.61
0.85
1.0
1.1
u/ml
2.5
3.6
—
7
21
(40761536) Microorganisms panel - Urine sediment
26
353
0.72
0.85
6.0
3.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
10
57
1.77
0.84
3.0
3.9
—
—
—
0
0
(3002256) Pathology report gross observation
59
483
1.25
0.83
1.2
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
20
138
1.47
0.82
1.6
1.8
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
8
47
1.71
0.81
1.1
1.2
nmol/l
1.1
1.2
—
8
42
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
20
139
1.46
0.80
2.5
3.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
33
1.83
0.79
1.7
2.2
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
6
33
1.83
0.79
3.3
2.7
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
25
0.00
0.79
0.0
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
8
48
1.68
0.79
1.0
1.4
nmol/l
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
12
74
1.64
0.78
1.0
1.1
u/ml
7.2
3.0
—
6
29
(3015171) Extractable nuclear Ab [Units/volume] in Serum
22
157
1.42
0.78
1.2
1.2
u/ml
0.2
2.3
—
5
12
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
27
0.00
0.77
0.0
1.0
—
238.5
—
0
27
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
28
209
1.36
0.77
2.5
1.7
mg/l
3.9
3.4
0.16
21
145
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
16
107
1.51
0.77
1.6
1.3
—
—
—
0
0
(4024509)
5
25
2.01
0.73
4.4
1.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
25
2.01
0.73
3.8
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
7
39
1.80
0.72
2.0
1.5
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
403
3876
1.15
0.72
21.7
14.8
%
13.6
13.5
0.56
398
3802
(3025468) Yersinia sp identified in Specimen by Organism specific culture
10
60
1.68
0.72
1.7
1.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
11
68
1.63
0.72
2.5
1.8
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
19
263
0.71
0.71
1.5
1.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
9
57
1.59
0.71
2.3
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
41
1.72
0.70
1.6
1.9
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
41
1.72
0.70
1.6
1.9
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
41
1.72
0.70
1.6
1.9
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
9
58
1.56
0.70
1.3
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
29
222
1.32
0.69
10.6
12.9
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
10
61
1.65
0.69
1.7
1.5
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
10
61
1.65
0.69
1.1
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
10
61
1.65
0.69
1.7
1.5
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
5
28
1.79
0.66
1.0
1.3
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
11
70
1.58
0.65
1.0
1.1
g/l
1.4
1.5
0.36
11
63
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
15
103
1.47
0.65
1.2
1.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
451
4383
1.15
0.65
18.3
12.8
%
41.3
41.4
0.10
359
3470
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
23
172
1.35
0.64
3.3
3.5
mmol/l
25.0
24.6
0.41
23
164
(3014133) Dog dander IgE Ab [Units/volume] in Serum
12
79
1.53
0.63
1.0
1.0
u/ml
1.9
2.4
—
7
30
(3024139) IgG subclass 3 [Mass/volume] in Serum
8
49
1.64
0.62
1.5
1.3
g/l
0.4
0.4
—
8
32
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
8
49
1.64
0.62
1.1
1.0
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
8
49
1.64
0.62
1.5
1.3
g/l
6.8
6.9
—
8
33
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
16
113
1.43
0.61
1.4
1.7
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
5
30
1.67
0.61
1.4
1.8
umol/l
14.8
12.3
—
5
30
(4062490)
8
50
1.61
0.61
1.5
1.3
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
13
88
1.49
0.61
1.2
1.1
—
10.7
—
0
9
(3048929) Epstein Barr virus Ab [Presence] in Serum
25
192
1.32
0.60
1.6
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
12
80
1.51
0.60
1.2
1.2
—
—
—
0
0
(3020891) Body temperature
21
157
1.35
0.60
6.0
4.9
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
15
107
1.41
0.56
2.6
1.7
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
32
258
1.26
0.55
1.6
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
9
63
1.44
0.52
2.7
2.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
17
126
1.36
0.52
1.6
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
83
1.46
0.52
1.2
1.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
6
40
1.51
0.51
2.7
2.3
pg
34.0
33.9
—
6
40
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
6
41
1.47
0.50
1.0
1.0
mg/l
293.3
290.1
—
6
36
(3038177) Helicobacter pylori Ab [Presence] in Serum
10
67
1.50
0.50
1.3
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
108
1186
0.89
0.50
3.4
2.6
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
7
46
1.53
0.48
1.7
1.9
—
35.4
—
0
7
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
47
1.50
0.47
1.1
1.3
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
81
0.61
0.46
5.2
3.4
%
51.8
55.1
—
5
81
(3051651) Icteric interference index of Serum or Plasma
5
31
1.62
0.43
2.0
4.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
15
113
1.34
0.43
1.5
1.7
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
6
92
0.65
0.42
1.7
1.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
19
149
1.28
0.42
2.6
4.2
g/l
0.2
0.2
—
9
79
(44790049)
8
58
1.38
0.41
1.4
1.6
—
—
—
0
0
(44790047)
8
58
1.38
0.41
1.4
1.6
—
—
—
0
0
(44790048)
8
58
1.38
0.41
1.4
1.6
—
—
—
0
0
(44806118)
8
58
1.38
0.41
1.4
1.6
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.1
—
6.8
—
0
5
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
24
197
1.23
0.38
1.2
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
36
1.39
0.38
1.0
1.4
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
36
1.39
0.38
1.2
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
36
1.39
0.38
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
36
1.39
0.38
1.2
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
113
1047
1.10
0.37
5.5
4.7
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
8
114
0.70
0.37
1.0
1.1
—
—
—
0
0
(3036489) Thrombin time
19
152
1.26
0.37
2.5
2.1
s
21.6
21.8
0.06
14
139
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
37
1.35
0.37
1.2
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
37
1.35
0.37
1.2
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
37
1.35
0.37
1.2
1.2
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
10
72
1.40
0.37
3.2
3.6
u/ml
10.4
3.5
—
10
67
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
12
90
1.34
0.36
1.1
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
78
0.64
0.36
5.2
3.2
e9/l
3.2
4.2
—
5
78
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
9
125
0.72
0.35
1.3
1.5
—
—
—
0
0
(4146454)
6
43
1.40
0.35
2.0
2.7
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
31
265
1.18
0.34
2.5
3.0
ng/l
130.5
131.9
0.01
26
235
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
6
45
1.34
0.34
1.3
1.2
—
—
—
0
0
(4010399)
34
294
1.17
0.33
1.3
1.4
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
6
46
1.31
0.33
1.2
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
63
571
1.12
0.32
2.1
1.7
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
11
83
1.33
0.32
1.0
3.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
7
96
0.73
0.31
4.0
3.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
10
75
1.34
0.30
1.9
1.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
7
56
1.25
0.29
1.6
1.1
—
—
—
0
0
(3013512) EKG study
116
1090
1.08
0.29
4.0
3.5
—
—
—
0
0
(3000492) Spirometry study
56
509
1.11
0.28
1.6
1.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
8
63
1.27
0.28
1.1
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
8
63
1.27
0.28
1.8
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
9
116
0.77
0.27
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
9
116
0.77
0.27
1.1
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
20
168
1.20
0.27
3.0
3.0
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
37
329
1.13
0.26
3.0
3.2
e9/l
4.1
4.1
0.05
32
271
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
16
132
1.22
0.26
2.5
2.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
15
181
0.82
0.25
1.8
1.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
53
484
1.11
0.25
5.2
4.1
%
29.6
30.1
0.13
41
350
(3005570) Glucose [Moles/volume] in Urine
5
38
1.32
0.23
2.6
1.4
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
5
42
1.19
0.21
1.6
2.1
e6/l
471.0
442.3
—
5
36
(1617658) Protocol used for examination of sentinel lymph nodes
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(4035726)
28
314
0.89
0.21
1.7
1.3
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
12
0.00
0.21
0.0
2.1
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
12
0.00
0.21
0.0
3.5
—
6397.1
—
0
12
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
43
1.16
0.21
1.2
1.9
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
14
0.00
0.20
0.0
1.3
—
7.5
—
0
14
(3029396) Erythrocyte agglutination [Presence] in Blood
0
14
0.00
0.20
0.0
3.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
141
1354
1.06
0.20
1.5
1.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
15
127
1.19
0.19
1.9
1.7
—
—
—
0
0
(40768793) Breast Pathology biopsy report
6
50
1.20
0.19
1.7
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
6
50
1.20
0.19
1.3
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
6
52
1.16
0.19
1.5
1.7
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
6
52
1.16
0.19
3.3
2.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
10
81
1.24
0.19
1.1
1.2
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
18
156
1.16
0.19
1.9
2.0
ug/l
0.6
1.7
0.98
18
140
(4268621)
6
53
1.13
0.18
3.5
2.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
66
0.76
0.17
1.0
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
68
0.73
0.17
1.6
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
70
0.71
0.17
2.0
2.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
8
68
1.18
0.16
1.4
1.4
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
9
78
1.16
0.15
1.1
1.2
—
43.9
—
0
7
(21494755) Public health laboratory ask at order entry panel
65
684
0.94
0.14
1.3
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
10
84
1.19
0.14
2.8
3.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
51
540
0.94
0.13
1.5
1.7
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
29
267
1.09
0.13
7.1
4.6
mmol/l
1.2
1.2
0.41
24
241
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
41
384
1.07
0.13
3.2
3.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
9
108
0.83
0.13
1.4
1.7
—
—
—
0
0
(3010421) pH of Blood
12
104
1.16
0.12
6.3
4.1
ph
7.4
7.4
—
7
87
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
62
649
0.95
0.12
1.3
1.4
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
19
172
1.11
0.11
3.9
7.5
%
2.2
1.6
0.81
19
160
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
87
1.15
0.09
1.2
1.5
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
48
1.04
0.09
1.2
1.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
57
1.05
0.08
1.0
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
16
146
1.10
0.08
1.3
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
65
1.08
0.08
1.3
1.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
6
71
0.84
0.07
1.0
1.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
9
84
1.07
0.07
1.3
1.8
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
9
85
1.06
0.07
1.3
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
12
109
1.10
0.06
1.6
1.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
34
354
0.96
0.05
3.7
5.3
ug/l
2.9
45.6
1.14
26
292
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
22
232
0.95
0.05
2.1
1.8
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
18
170
1.06
0.04
4.1
7.6
%
0.9
0.9
0.07
18
159
(3027273) Bicarbonate [Moles/volume] in Venous blood
20
193
1.04
0.01
5.1
3.1
mmol/l
25.7
24.7
0.77
20
186
(3023511) Choriogonadotropin [Units/volume] in Urine
10
95
1.05
0.00
1.2
1.2
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
14
136
1.03
0.00
2.1
1.5
g/l
0.2
0.2
0.14
14
131
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
14
144
0.97
0.00
2.2
1.5
g/l
1.2
1.2
0.10
14
138
(3039000) Anion gap in Blood
10
99
1.01
0.00
3.9
10.9
mmol/l
14.5
11.5
—
10
91
(3018572) Chloride [Moles/volume] in Blood
10
99
1.01
0.00
3.9
10.9
mmol/l
105.3
105.3
—
10
91
(3044941) Cell count panel - Synovial fluid
6
66
0.91
0.00
1.2
1.3
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
1.4
—
0
5
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
9
0.00
0.00
0.0
10.3
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
8
0.00
0.00
0.0
6.8
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
5
0.00
0.00
0.0
2.0
—
0.6
—
0
5
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
9
0.00
0.00
0.0
2.9
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
42.2
—
0
5
(3008402) Methanol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
4.2
—
—
—
0
0
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
2.6
—
0
6
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
62
0.97
0.00
12.3
3.5
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.6
—
193.2
—
0
5
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
17
170
1.00
0.00
1.4
1.4
miu/ml
175.5
240.6
—
8
83
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
7
74
0.95
0.00
1.3
1.6
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013762) Body weight Measured
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3026726) Creatinine [Moles/volume] in Specimen
0
5
0.00
0.00
0.0
1.4
—
90.2
—
0
5
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
55
0.91
0.00
1.0
1.2
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
6
0.00
0.00
0.0
3.5
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
0
5
0.00
0.00
0.0
1.2
—
26.6
—
0
5
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
9
94
0.96
0.00
1.1
1.4
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
7
79
0.88
0.00
1.9
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
74
0.95
0.00
1.4
1.5
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
63
0.95
0.00
2.0
1.6
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint F5_SEXDYS and mortality.

Females

No data

Males

Parameter HR [95% CI] p-value
F5_SEXDYS 1.439 [1.19, 1.75] < 0.001
Birth year 0.988 [0.98, 1.0] 0.026

During the follow-up period (1.1.1998 — 31.12.2019), 176 out of 1694 males with F5_SEXDYS died.

Mortality risk

Mortality risk for people of age

years, who have F5_SEXDYS.

N-year risk Females Males
1 No data 0.287%
5 No data 1.854%
10 No data 4.492%
15 No data 8.385%
20 No data 14.164%

Relationships between endpoints

↥

Index endpoint: F5_SEXDYS – Sexual dysfunction

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data